Prestige Consumer Healthcare Inc. Stock
There is an upward development for Prestige Consumer Healthcare Inc. compared to yesterday, with an increase of €0.80 (1.830%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 61 € there is a positive potential of 36.77% for Prestige Consumer Healthcare Inc. compared to the current price of 44.6 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 1.830% | 0.000% | 4.695% | -28.640% | -16.636% | -26.281% | -0.446% |
| Apollo Medical Holdings, Inc. | 0.000% | -7.186% | -27.230% | 64.894% | 46.226% | -9.357% | -60.000% |
| Petmed Express Inc | -1.980% | -1.992% | -1.768% | -37.563% | -40.333% | -85.715% | -93.076% |
| Suzuken Co Ltd | -1.520% | -6.383% | 0.000% | 5.600% | -19.512% | 5.600% | 7.317% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat